Celularity, Inc. (CELU) vs Evaxion A/S - Sponsored ADR (EVAX)

Celularity, Inc. and Evaxion A/S - Sponsored ADR are both Biotechnology companies. Celularity, Inc. and Evaxion A/S - Sponsored ADR are of similar size ($23.5M and $23.0M). Evaxion A/S - Sponsored ADR has the higher net margin (0.00% vs −247.7%) and the higher return on invested capital (−245.8% vs −462.8%). Across the 15 metrics below, Evaxion A/S - Sponsored ADR leads on 10 and Celularity, Inc. on 5.

Valuation

Metric CELU EVAX Biotechnology median
P/E n/m n/m 10.60
P/S 1.19 2.06 9.40
P/B n/m 2.31 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 3.45 1.38 9.02
Earnings yield (222.37%) (32.88%) (32.88%)
Free cash flow yield (40.93%) (139.47%) (23.13%)

Profitability

Metric CELU EVAX Biotechnology median
Gross margin 19.23% 100.00% 68.51%
Operating margin (264.27%) 0.00% 0.00%
Net margin (247.71%) 0.00% 0.00%
Free cash flow margin (47.80%) 0.00% 0.00%
Return on equity 151.53% (96.10%) (51.96%)
Return on assets (42.72%) (36.20%) (46.06%)
Return on invested capital (462.77%) (245.79%) 0.00%

Growth

Metric CELU EVAX Biotechnology median
Revenue growth (TTM) (58.14%) — 6.76%
EPS growth (last fiscal year) (35.98%) 87.79% 29.88%
Revenue growth, 5-year CAGR 13.21% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CELU EVAX Biotechnology median
Debt to equity (1.20) 0.71 0.00
Current ratio 0.11 5.06 4.97
Net debt to EBITDA (0.77) 1.87 1.01

Dividend

Metric CELU EVAX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CELU EVAX Biotechnology median
Market cap 23.54m 23.02m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack